While there is growing acknowledgment of the importance of equity considerations in global health governance more generally, there is also growing evidence that equity issues are central to addressing Infectious Diseases (IDs) and Antimicrobial Resistance (AMR) through global governance arrangements. Sex and gender identity are key health equity stratifiers globally with implications for ID and AMR prevention and control. For example, women with lower levels of education or resources, or who live in rural or remote areas, may face greater exposure to health care settings without safe or hygienic conditions and, if they contract an AMR infection, may be less likely to receive, or less able to afford, the needed first and second-line treatments than men. Similarly, certain population groups living in conditions disadvantaged by poverty (absolute and relative), ethnicity, or geography may be at greater risk of contracting IDs in general, and AMR strains in particular; and may have different abilities to access and adhere to treatment guidelines. This research stream will focus on identifying best practice guidelines for how to ensure equity considerations are considered in the design of effective global governance systems for ID and AMR.